Search

everythinglearnresearchcommunity

for

Search:↓

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Iron deficiency may contribute to hair loss.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

The study concluded that neonatal occipital alopecia is common, not caused by physical friction, and usually resolves on its own without treatment.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Korean psoriasis patients still use alternative medicine despite effective biologics.

Rural Bangladeshi girls mature later than peers in other low and middle-income countries due to poor nutrition and socioeconomic conditions.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

COVID-19 may trigger alopecia areata, but more research is needed.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Covid-19 worsens existing health issues and long-term effects are predictable.

Medications improve quality of life for men with lower urinary tract symptoms.

Surgery, especially prostatectomy, effectively reduces detrusor overactivity in bladder outlet obstruction patients.